Gilead Details Promising Early COVID Antiviral Data, Setting Up Larger Studies ...Middle East

Medscape - News
Gilead Sciences on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy volunteers cleared the way for two large Phase III trials. Reuters Health Information

Hence then, the article about gilead details promising early covid antiviral data setting up larger studies was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gilead Details Promising Early COVID Antiviral Data, Setting Up Larger Studies )

Apple Storegoogle play

Last updated :

Also on site :



Latest News